FyoniBio has over 15 years of experience in contract development services, delivering innovative scientific solutions for biopharmaceutical development. We provide ISO-9001:2015 fully-integrated services from high titer stable cell line development within mammalian expression systems and robust process development, up to drug quality control and broad bioanalytical capabilities for preclinical and clinical studies.

A special focus lies on drug glycosylation as this is a critical quality attribute of biopharmaceuticals which can affect drug clearance, potency and safety as well as productivity. All these aspects are addressed by FyoniBio´s human GlycoExpress® cells as well as the CHO platform technology CHOnamite® coupled with upstream and downstream process optimization, state-of-the-art equipment and in-house developed software for glycan analytics. The service portfolio is complemented by GCLP-compliant bioanalysis of clinical samples.